⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

VTRS

Viatris Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

18.00USD

-0.4800 (-2.60%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on VTRS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 18.00
P/E—
Dvd Ind Yld2.7%
P/B1.45
P/S1.4
Curr EV/T12M EBITDA12.1
Mkt Cap (USD)20.7B
Curr EV (USD)32.8B
2)

Per Share Data

EPS T12M-0.36
DPS0.48
Bk Val Per Sh12.34
Rev/Sh12.63
Cash/Sh1.32
Curr Shares Out1,148.6M
FCF/Sh1.68
3)

Cash Flow Analysis

P/CF8.9
Curr P/FCF10.6
CF/NI-3.5
Dvd P/O960.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales15.9%
Eff Interest Rate3.5%
4)

Growth Potential

Dil EPS 1Y Gr-466.0%
Cap 1Y Gr-10.9%
BPS 1Y Gr-2.0%
R&D To Sales6.6%
Retention Rate-860.0%
Rev 1Y Gr-3.0%
FCF 1Y Gr-2.0%
Assets 1Y Gr-10.4%
5)

Profitability

EBITDA2.7B
EBIT-0.1B
Operating Margin-0.6%
Pretax Margin-4.5%
Net Margin-4.6%
ROA-1.8%
ROE-4.5%
ROC-0.2%
Asset Turnover0.40
6)

Structure

Current Ratio1.58
Quick Ratio0.82
Debt/Assets38.1%
Debt/Com Eq93.6%
Net Debt/EBITDA4.59
Tot Debt/Capital48.3%
Gross Margin34.9%
EBIT/Int Exp-0.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.